Potassium preparation

Kali-kugel, /. potash bulb, -lauge, /. potash lye, caustic potash solution, -losung, /. potash solution, -metall, n. (metallic) potassium. -olivenolseife, /. potash olive oil soap, -praparat, n. potash (or potassium) preparation. -reibe,/. (Petro. ) potash series, -roh-salz, n. crude potassium salt, -salpeter, m. 

The most effective synthetic control of the thiolation of bismuth has been achieved using reactions of bismuth chloride with aminothiolate salts (potassium) prepared in situ. Although the reactions are not quantitative, the molecular stoichiometry can be reliably selected and a systematic series of mono-, bis-, and tris-thiolates have been isolated and comprehensively characterized. (189). 

Reserve slow release potassium chloride preparations for patients who cannot tolerate liquids or effervescent potassium preparations, or for patients in whom there is a problem of compliance with these preparations. 

IV Do not administer undiluted potassium - Potassium preparations must be diluted with suitable large volume parenteral solutions, mixed well and given by slow IV infusion. 

Drugs that may affect ACEIs may include antacids, capsaicin, indomethacin, phenothiazines, probenecid, and rifampin. Drugs that may be affected by ACEIs include allopurinol, digoxin, lithium, potassium preparations/potassium-sparing diuretics, and tetracycline. 

Drugs that may interact include digoxin, potassium preparations, ACE inhibitors, and NSAIDs. 

Drugs that may affect spironolactone include ACE inhibitors, salicylates, and food. Drugs that may be affected by spironolactone include anticoagulants, digitalis glycosides, mitotane, digoxin, and potassium preparations. 

Amiloride is used with thiazide or loop diuretics in hypertension, in congestive heart failure, in digitalis-induced hypokalemia, and in arrhythmias resulting from hypokalemia. Inappropriate use of amiloride may cause hyperkalemia (potassium >5.5 mEq/L), which may be fatal if not corrected, and may be more deleterious in elderly individuals and in patients with diabetes mellitus and renal impairment. The symptoms of hyperkalemia include fatigue, flaccid paralysis of the extremities, paresthesias, bradycardia, ECG abnormalities, and shock. Amiloride is not metabolized but is contraindicated in anuria, acute or chronic renal insufficiency, or in diabetic nephropathy. It should not be used with potassium preparations, and should be used cautiously with ACE inhibitors because these agents cause hyperkalemia. 

The critical character of some potassium preparations was mentioned in the previous section. An increase of potassium ion in the isopropoxide component from 0.75 to 0.87 mole caused a rapid drop from 2.8 to 1.2 for the ratio of trans-l, 4- to 1,2-polymer. Such rapid changes from one level of activity to another indicate the special effect of the surface. 

B. Parenteral administration. Note DO NOT use undiluted Injectable potassium preparations direct injection can be lethal if given too rapidly pain at the injection site and phlebitis may occur, especially during Infusion of solutions containing greater than 30 mEq/L. 

A reference solution is used to compensate for the influence of the potassium. It consists of a precipitate of a quantity of potassium, prepared in the same way, corresponding to the content of potassium ions in the quantity of water used for the rubidium and caesium determination. This generally entails no particular difficulty since a determination of potassium precedes the determination of Rb and Cs in the course of w.ater analysis. Experience shows that the potassium content in water hardly ever exceeds 300 mg/1. Consequently, the method has been adapted to a constant potassium content of 200 mg/1, which may be achieved by adding potassium chloride if the content of the natural water sample is lower. 

Tertiary butyl alcohol, trimethyl carbinol, tertiary butanol. 2-methyl-2-propanol, Me3COH. Colourless prisms, m.p. 25°C, b.p. 83°C. Prepared by absorbing isobutene (2-methylpropene) in sulphuric acid, neutralizing and steam distilling the liquor. Converted to isobutene by heating with oxalic acid. Potassium-/-buloxide is a very strong base. 

CH3CH2)2S. a colourless liquid with an ethereal odour when pure usually it has a strong garlic-like odour b.p. 92°C. Prepared by the action of KHS on ethyl chloride or potassium ethyl sulphate. When heated at 400-500°C it forms thiophene. 

C. It occurs in natural gas. May prepared by reduction of ethene or ethyne by hydrogen under pressure in the presence of a nickel catalyst, or by the electrolysis of a solution of potassium elhanoate. It has the general properties of the paraffins. Used in low-temperature refrigeration plant. 

CH3)2N]3P0. M.p. 4°C, b.p. 232"C, dielectric constant 30 at 25 C. Can be prepared from dimethylamine and phosphorus oxychloride. Used as an aprotic solvent, similar to liquid ammonia in solvent power but easier to handle. Solvent for organolithium compounds, Grignard reagents and the metals lithium, sodium and potassium (the latter metals give blue solutions). 

White crystals m.p. 162-164 C. ll can be prepared by the fermentation of sugar with the mould Aspergillus lerreus or by healing citra-conic anhydride with water at ISO C. Electrolysis of the potassium salt in solution gives allene. Itaconic acid is used as a comonomer in plastics its esters are polymerized to lubricating oils and plasticizers. 

Colourless prisms m.p. 130 C. Manufactured by treating maleic anhydride with water. It is converted to the anhydride by heating at By prolonged heating at 150 "C or by heating with water under pressure at 200 C, it is converted to the isomeric (trans) fumaric acid. Reduced by hydrogen to succinic acid. Oxidized by alkaline solutions of potassium permanganate to mesotartaric acid. When heated with solutions of sodium hydroxide at 100 C, sodium( )-malate is formed. Used in the preparation of ( )-malic acid and in some polymer formulations. 

CH OfiSj, H2C(S03H)2- a colourless, crystalline solid which readily absorbs water vapour decomposes on distillation. The potassium salt is prepared by heating methylene chloride with an aqueous solution of potassium sulphite under pressure at 150-I60" C. The free acid is obtained by decomposing the sparingly soluble barium salt with sulphuric acid. The aryl esters are very stable, but the alkyl esters decompose on heating to give ethers. Resembles malonic acid in some of its reactions. 

---